- Home
- BPTH vs CRKN Comparison
BPTH vs CRKN Comparison
Compare BPTH & CRKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- CRKN
- Stock Information
- Founded
- BPTH 2007
- CRKN 2015
- Country
- BPTH United States
- CRKN United States
- Employees
- BPTH N/A
- CRKN N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- CRKN Industrial Machinery/Components
- Sector
- BPTH Health Care
- CRKN Technology
- Exchange
- BPTH Nasdaq
- CRKN Nasdaq
- Market Cap
- BPTH 5.0M
- CRKN 2.6M
- IPO Year
- BPTH N/A
- CRKN N/A
- Fundamental
- Price
- BPTH $1.09
- CRKN $0.13
- Analyst Decision
- BPTH Strong Buy
- CRKN
- Analyst Count
- BPTH 2
- CRKN 0
- Target Price
- BPTH $30.00
- CRKN N/A
- AVG Volume (30 Days)
- BPTH 6.2M
- CRKN 52.7M
- Earning Date
- BPTH 11-15-2024
- CRKN 11-14-2024
- Dividend Yield
- BPTH N/A
- CRKN N/A
- EPS Growth
- BPTH N/A
- CRKN N/A
- EPS
- BPTH N/A
- CRKN N/A
- Revenue
- BPTH N/A
- CRKN $13,461,000.00
- Revenue This Year
- BPTH N/A
- CRKN N/A
- Revenue Next Year
- BPTH N/A
- CRKN N/A
- P/E Ratio
- BPTH N/A
- CRKN N/A
- Revenue Growth
- BPTH N/A
- CRKN 22715.25
- 52 Week Low
- BPTH $0.59
- CRKN $0.12
- 52 Week High
- BPTH $12.00
- CRKN $90.00
- Technical
- Relative Strength Index (RSI)
- BPTH 54.13
- CRKN 17.19
- Support Level
- BPTH $1.11
- CRKN $0.13
- Resistance Level
- BPTH $1.34
- CRKN $0.23
- Average True Range (ATR)
- BPTH 0.30
- CRKN 0.03
- MACD
- BPTH 0.02
- CRKN 0.03
- Stochastic Oscillator
- BPTH 16.36
- CRKN 10.19
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About CRKN Crown Electrokinetics Corp.
Crown ElectroKinetics Corp is a provider of DynamicTint. The company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications to a wide array of windows, including commercial buildings, automotive sunroofs, and residential skylights, Crown partners with glass and film manufacturers for mass production and distribution. Its technology is a thin film that is powered by an electrically-charged pigment which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. It is supported by a robust patent portfolio.